PNPLA3 and metabolic dysfunction-associated steatotic liver disease: PNPLA3-I148M is proportionally overrepresented in the Hispanic population (0.49 in Hispanics, 0.23 in European-Americans and 0.17 in African-Americans), which may partially explain the higher susceptibility Hispanic people to NAFLD (Romeo et al., 2008).